BNP Paribas Financial Markets Takes Position in Cullinan Therapeutics, Inc. (NASDAQ:CGEM)
BNP Paribas Financial Markets purchased a new stake in Cullinan Therapeutics, Inc. (NASDAQ:CGEM – Free Report) during the 4th quarter, according to its most recent Form 13F filing with the SEC. The institutional investor purchased 115,000 shares of the company’s stock, valued at approximately $1,401,000. Several other large investors have also recently bought and sold […]
BNP Paribas Financial Markets purchased a new stake in Cullinan Therapeutics, Inc. (NASDAQ:CGEM – Free Report) during the 4th quarter, according to its most recent Form 13F filing with the SEC. The institutional investor purchased 115,000 shares of the company’s stock, valued at approximately $1,401,000. Several other large investors have also recently bought and sold […]
